Profile data is unavailable for this security.
About the company
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
- Revenue in USD (TTM)0.00
- Net income in USD-8.44m
- Incorporated2017
- Employees--
- LocationClearmind Medicine Inc101-1220 West 6Th AvenueVANCOUVER V6H 1A5CanadaCAN
- Phone+1 (604) 260-1566
- Fax+1 (604) 689-2646
- Websitehttps://www.clearmindmedicine.com/
More ▼
Holder | Shares | % Held |
---|---|---|
Iroquois Capital Management LLCas of 11 Jan 2024 | 125.00k | 3.94% |
AdvisorShares Investments LLCas of 31 Dec 2023 | 92.69k | 2.92% |
G1 Execution Services LLCas of 31 Mar 2024 | 23.98k | 0.76% |
Cornerstone Wealth Group LLCas of 30 Jun 2024 | 20.00k | 0.63% |
Geode Capital Management LLCas of 30 Jun 2024 | 16.58k | 0.52% |
RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 2024 | 569.00 | 0.02% |
More ▼
Data from 31 Mar 2024 - 11 Jul 2024Source: FactSet Research Systems Inc.